AGP Picks
View all

AGP Executive Report

Last update: 8 hours ago

Diabetes Tech & Care Access: A new ADA 2026 study found continuous glucose monitoring (CGM) can improve glucose control for adults with type 2 diabetes not using insulin, using the CONNECT trial to compare CGM vs routine fingerstick care. Obesity Drug Pipeline: Multiple ADA 2026 updates spotlight next-gen weight-loss options, including Novo Nordisk’s CagriSema (amylin + GLP-1) showing significant HbA1c and weight reductions, plus Boehringer/Zealand’s survodutide reporting weight and liver-fat benefits in phase 3 trials. Nursing Home Watch: CMS data for Q1 2026 show Heritage Manor South (Caddo) owned by ACT Investments/Medico with a 4-star overall rating, while Rosewood Nursing Center (Calcasieu) scored 2 with fines/penalties, and St. Bernard Nursing & Rehab (Orleans) scored 2. Public Health & Research Freedom: Police removed diabetes researchers from an ADA New Orleans conference after they distributed an editorial criticizing federal biomedical research cuts. Louisiana Safety Alerts: A Silver Alert was issued for a Port Allen man with a medical condition that may impair judgment; and Louisiana State Police reported a fatal UTV crash in Washington Parish where the driver was unrestrained. Community Health: Saints fans backed a St. Jude fundraiser in New Orleans with podcaster Tom Grossi.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
3 hours ago

Chopin Law Firm opens Lafayette office to expand South Louisiana access

EIN Presswire

fallback image
Jun. 4, 2026

Dr. Patrick Savoy launches integrative health platform in Central Louisiana

EIN Presswire

fallback image
Jun. 1, 2026

MOPE Clinic spotlights hormones, sleep and metabolic health concerns in South Louisiana

EIN Presswire

fallback image
Jun. 1, 2026

Chopin Law Firm opens Covington office to serve Northshore clients

EIN Presswire


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Intermountain Primary Children’s Hospital joins national trauma and grief network

Intermountain Primary Children’s Hospital joins national trauma and grief network

2 Gulf Coast cities getting their first dispensaries as medical marijuana expands in Alabama

2 Gulf Coast cities getting their first dispensaries as medical marijuana expands in Alabama

Community Divided Over South Louisiana School's Social Media Ban

Community Divided Over South Louisiana School's Social Media Ban

Commentary: RFK Jr.’s actions empower lawyers at the expense of Americans’ health — Matthew Kandrach

Commentary: RFK Jr.’s actions empower lawyers at the expense of Americans’ health — Matthew Kandrach

Baton Rouge walkers of Camino de Santiago share stories of churros, chocolate, beauty and pain

Baton Rouge walkers of Camino de Santiago share stories of churros, chocolate, beauty and pain

Quin Hillyer: Louisiana AG Liz Murrill brought home common-sense wins this legislative session

Quin Hillyer: Louisiana AG Liz Murrill brought home common-sense wins this legislative session


fallback image
31 minutes ago

MOPE Clinic Highlights Lab-Based Health Optimization Trends for 2026

EIN Presswire

fallback image
3 hours ago

Chopin Law Firm Adds Lafayette Location to Better Serve South Louisiana Clients

EIN Presswire

fallback image
6 hours ago

Eledon Announces Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes (T1D) at UChicago Medicine

GlobeNewswire, Inc.

fallback image
Jun. 7, 2026

Zealand Pharma announces Boehringer Ingelheim's survodutide Phase III trial in people living with obesity showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis

GlobeNewswire, Inc.

fallback image
Jun. 7, 2026

Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss in pre-specified analysis, supporting improved metabolic health in people living with obesity

GlobeNewswire, Inc.

fallback image
6 hours ago

Sequel Presents Pivotal Trial of the twiist™ Automated Insulin Delivery System in Adults with Insulin-Treated Type 2 Diabetes at the ADA 86th Scientific Sessions

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Robot Dogs and High-Tech Drones — Inside FIFA World Cup Security
Play
Robot Dogs and High-Tech Drones — Inside FIFA World Cup Security
YouTube video thumbnail: Intense Storms Batter Millions in the Northeast
Play
Intense Storms Batter Millions in the Northeast
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: World Cup Sparks Boom in U.S. Youth Soccer
Play
World Cup Sparks Boom in U.S. Youth Soccer
YouTube video thumbnail: Trump Says he Calls 'all the Shots' After Israeli Strikes on Iran
Play
Trump Says he Calls 'all the Shots' After Israeli Strikes on Iran

Video Title

Sign up for:

Louisiana Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Sign up for:

Louisiana Health Daily

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.